top of page

News & Insights 

Double Helix Law Turns 10!

Updated: Apr 7

This week, we’re celebrating a decade of helping life sciences innovators protect their groundbreaking IP.

We are grateful for every client and team member who’s been part of this journey.



To Our Clients

Thank you for trusting us with your breakthrough technologies. Your innovations inspire us every day.


To Our Lean, Mean DHL Dream Team:

  • Mike Mand, JD, PhD – 9 DHL years: A powerhouse blend of legal acumen and deep biotech insight

  • Vasanth Vaidyanathan, PhD – 4 DHL years: International patent pro + seasoned biotech brain

  • Judy Huerta – 3 DHL years: Paralegal extraordinaire and USPTO rules wizard

  • Dominic Vacchiano – 1 DHL year: Unique experience in biopharma, software, and AI


What Makes Us Different (Still):

  • Experts in building biotech patent portfolios aligned with your evolving clinical and business strategies

  • Adept in using proactive and advanced approaches to get difficult biotech patents issued

  • Experienced at helping clients design around biotech patent thickets

  • Proudly non-traditional: no silos, no ivory towers

  • Virtual-first = more time focused on building our clients' patent estates

  • Competitive rates = more time to build your portfolio and stay clear of your competitors'

  • Deeply embedded in your teams, science and strategy


Thanks for an incredible decade of trust, collaboration, and discovery.

Here’s to the next chapter in biotech IP — and continuing to build differently, together.



 


About DHL

Double Helix Law (DHL) has decades of experience building strong patent portfolios for life science companies. Learn more about DHL and meet the team.

Want to stay updated on life science patent law? Subscribe to get notified of updates



 


The content on this website (including all pages, articles, and comments) is not legal advice, and does not and is not intended to form or constitute any attorney-client relationship. The content is not a solicitation for business; it is for educational and entertainment purposes only, and reflects the personal views of the author(s) only and not those of any past, present, or future client of DHL. Any content should be double-checked for accuracy and current applicability, and liability is disclaimed for any error or omission.



04/04/25 Published (EJV)

Comments


Get the latest DHL news and life science patent and investor insights right in your mailbox!

Thanks for subscribing!

bottom of page